Long-Term Outcomes with Islet-Alone and Islet-after-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study

This was a prospective interventional and observational cohort study of islet-alone and islet-after-kidney transplant recipients followed for up to eight years after intraportal infusion of one or more purified human pancreatic islet products under standardized immunosuppression.